Recommended Global Oncology & Cancer Webinars & Conferences
Asia Pacific & Middle East
Canada
Preventive Oncology 2025
- About Conference
- Why Attend?
- Who Can Attend?
- Scientific Sessions
- Participation Benefits
- Global Associations, Societies & Universities
- Market Analysis
About Conference
Welcome to the 38th Conference on Preventive Oncology and Diagnostic Cancer, scheduled for May 05-06, 2025, in the beautiful city of Rome, Italy. Preventive Oncology Conference will gather global experts in the fields of oncology, diagnostics, and cancer prevention to discuss innovations and breakthroughs aimed at reducing cancer incidence worldwide. The conference will provide an interdisciplinary platform for scientists, healthcare professionals, industry leaders, and students to share their expertise and collaborate on the most pressing issues in oncology today.
Conference Theme: "Innovative Approaches in Cancer Prevention and Early Diagnosis: Pioneering the Future of Oncology"
The theme of Preventive Oncology 2025 focuses on the critical role of early detection, cutting-edge diagnostic technologies, and preventive strategies in reducing cancer mortality. As cancer remains one of the leading causes of death worldwide, this event aims to foster collaboration and knowledge exchange to drive advancements in prevention and diagnostics, ultimately improving patient outcomes and global health.
Abstract Submission is now open, and we invite researchers and professionals to contribute their latest findings. Early submissions will benefit from reduced registration fees and prioritized presentation opportunities. Ensure to register early to secure your spot at this groundbreaking event!
Why Attend?
The 38th Conference on Preventive Oncology and Diagnostic Cancer provides a unique opportunity to:
- Engage with Global Experts: Hear from leading oncologists, researchers, and healthcare practitioners who are driving innovations in cancer prevention and diagnostics.
- Stay Ahead of Trends: Learn about the latest research, cutting-edge technologies, and clinical practices that are shaping the future of oncology.
- Build Your Network: Interact with professionals and thought leaders from around the world, fostering potential collaborations and partnerships.
- Present Your Work: Showcase your research findings to a global audience and receive valuable feedback from peers and experts in the field.
- Discover Rome: Experience the rich history, culture, and cuisine of Rome while attending a world-class scientific event.
Who Can Attend?
This conference welcomes participants from a wide range of professions, including:
- Oncologists and Hematologists
- Cancer Researchers and Scientists
- Pathologists and Diagnostic Specialists
- Radiologists and Imaging Experts
- Epidemiologists and Public Health Professionals
- Healthcare Providers and Clinicians
- Pharmaceutical and Biotech Professionals
- Medical Device Manufacturers
- Graduate and Postgraduate Students
- Cancer Advocacy Groups
- Medical Directors and Healthcare Administrators
Scientific Sessions
Track 1. Advances in Cancer Prevention and Risk Assessment
Track 2. Innovations in Cancer Diagnostics and Early Detection
Track 3. Cancer Epidemiology and Biomarkers
Track 4. Personalized Cancer Medicine and Targeted Therapy
Track 5. Molecular Oncology: From Bench to Bedside
Track 6. Novel Screening Methods for Early Detection
Track 7. Cancer Immunology and Immunotherapy
Track 8. Role of AI and Machine Learning in Cancer Diagnosis
Track 9. Preventive Oncology in Low- and Middle-Income Countries
Track 10. Genetic and Environmental Factors in Cancer Development
Track 11. Nutrition, Lifestyle, and Cancer Prevention
Track 12. Diagnostic Imaging in Cancer: Innovations and Future Directions
Track 13. Tumor Microenvironment and Its Role in Cancer Progression
Track 14. Cancer Genomics and Precision Oncology
Track 15. Public Health Strategies in Reducing Cancer Burden
Participation Benefits
Attendees of the 38th Conference on Preventive Oncology and Diagnostic Cancer will enjoy a variety of exclusive benefits, including:
- Certification of Participation to recognize your involvement in the conference.
- Access to All Scientific Sessions and interactive workshops.
- Opportunities to Present Research and receive feedback from leading experts in oncology.
- Networking Opportunities with top professionals, researchers, and organizations in the field.
- Published Abstracts in indexed scientific journals, offering global exposure for your work.
- Exclusive Conference Kit including materials and resources.
- Award Eligibility for the best presentations, posters, and research contributions.
Global Associations, Societies & Universities
Top 20 Global Associates:
- American Association for Cancer Research (AACR) - aacr.org
- American Society of Clinical Oncology (ASCO) - asco.org
- European Society for Medical Oncology (ESMO) - esmo.org
- International Agency for Research on Cancer (IARC) - iarc.fr
- World Health Organization (WHO) - who.int
- National Cancer Institute (NCI) - cancer.gov
- International Union Against Cancer (UICC) - uicc.org
- Cancer Research UK - cancerresearchuk.org
- American Cancer Society (ACS) - cancer.org
- European Association for Cancer Research (EACR) - eacr.org
- Canadian Cancer Society - cancer.ca
- Asian Pacific Organization for Cancer Prevention (APOCP) - apocp.org
- Australasian Society for Breast Disease (ASBD) - asbd.org.au
- Union for International Cancer Control (UICC) - uicc.org
- Oncology Nursing Society (ONS) - ons.org
- Japanese Cancer Association (JCA) - jca.gr.jp
- Society of Surgical Oncology (SSO) - surgonc.org
- National Comprehensive Cancer Network (NCCN) - nccn.org
- Society for Immunotherapy of Cancer (SITC) - sitcancer.org
- European Cancer Organisation (ECCO) - europeancancer.org
Top 20 Societies:
- American Society of Preventive Oncology (ASPO) - aspo.org
- European Society for Preventive Oncology (ESPO) - espo.eu.com
- International Society for Preventive Oncology (ISPO) - cancerprev.org
- Society for Cancer Prevention (SCP) - socprev.org
- Prevent Cancer Foundation - preventcancer.org
- British Society for Immunology - immunology.org
- Society for Integrative Oncology (SIO) - integrativeonc.org
- Association of Community Cancer Centers (ACCC) - accc-cancer.org
- European Society of Breast Cancer Specialists (EUSOMA) - eusoma.org
- National Society of Genetic Counselors (NSGC) - nsgc.org
- International Psycho-Oncology Society (IPOS) - ipos-society.org
- Oncology Nursing Society (ONS) - ons.org
- International Association for the Study of Lung Cancer (IASLC) - iaslc.org
- American Radium Society (ARS) - americanradiumsociety.org
- European Society of Gynecological Oncology (ESGO) - esgo.org
- European Oncology Nursing Society (EONS) - cancernurse.eu
- Society for Translational Oncology (STO) - sto-online.org
- Association of European Cancer Leagues (ECL) - europeancancerleagues.org
- World Federation of Surgical Oncology Societies (WFSOS) - wfsos.org
- International Society for Pediatric Oncology (SIOP) - siop-online.org
Top 20 Universities:
- Harvard University - harvard.edu
- University of Oxford - ox.ac.uk
- Stanford University - stanford.edu
- University of Cambridge - cam.ac.uk
- Johns Hopkins University - jhu.edu
- Massachusetts Institute of Technology (MIT) - mit.edu
- University of California, San Francisco (UCSF) - ucsf.edu
- University of California, Los Angeles (UCLA) - ucla.edu
- University of Toronto - utoronto.ca
- Karolinska Institute - ki.se
- Imperial College London - imperial.ac.uk
- University of Sydney - sydney.edu.au
- University of Melbourne - unimelb.edu.au
- National University of Singapore (NUS) - nus.edu.sg
- University of Tokyo - u-tokyo.ac.jp
- University of Pennsylvania (Penn) - upenn.edu
- University of Chicago - uchicago.edu
- Yale University - yale.edu
- University of Michigan - umich.edu
- University of Washington - washington.edu
Market Analysis
The global cancer diagnostics market is projected to reach USD 106.24 billion by 2024 and grow to USD 156.97 billion by 2029, with a compound annual growth rate (CAGR) of 8.12% during this period.
The COVID-19 pandemic significantly impacted the industry, leading to a sharp decline in cancer diagnostics, particularly in colorectal cancer screenings, where referrals dropped by 31% during the first wave. Endoscopic diagnostic procedures were halted to prevent virus transmission, causing delays in cancer care. However, post-pandemic, the market has recovered, with diagnostic procedures returning to pre-pandemic levels. The market is expected to grow robustly with the easing of restrictions.
Several key factors are driving this expansion:
-
Rising global cancer prevalence: The global cancer burden continues to increase, with an aging population contributing significantly to this rise. In 2022, approximately 233,900 Canadians were living with cancer, and by 2040, the number of cancer cases worldwide is projected to exceed 30 million, according to Globocan.
-
Advancements in diagnostic technologies: Innovations such as biomarkers, liquid biopsies, and point-of-care testing have improved early detection, precision, and accessibility, further propelling market growth.
To Collaborate Scientific Professionals around the World
Conference Date May 05-06, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by